Home Study CME Enrollment Form/Questionnaire

Program Description and Objective: The Journal of Urology® Home Study Course is a comprehensive learning activitydeveloped by a team of educators, academicians, and clinicians. After completing the program, urologists will be able to demonstratean increase in or affirmation of their knowledge of clinical medicine. They will also be able to evaluate the appropriateness of clinicaldata and apply it to their practice and to the provision of patient care.

Program Format: To receive Category 1 CME Credit hours for The Journal of Urology ® Home Study, submit The Journal ofUrology ® Home Study CME Enrollment Form with payment of $60.00. Once AUA receives your Journal of Urology Home StudyCME Enrollment Form and payment, answer sheets are mailed to you. Five articles are selected by the editor to be read in eachissue. Answer five questions on the answer sheet. Return completed answer sheets in the provided envelope. Completion of each testand a score of 80% or more qualify for 2 hours Category 1 CME Credit hours.

Accreditation: The American Urological Association Education and Research, Inc. is accredited by the Accreditation Council forContinuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. The American UrologicalAssociation Education and Research, Inc. takes responsibility for the content, quality, and scientific integrity of the CME activity.

CME Credit: The American Urological Association Education and Research, Inc. designates this educational activity for amaximum of 24 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those creditsthat he/she actually spent in the educational activity.

See page 329 for questionnaire

The Journal of Urology® Home Study Program Registration Form

Volume #

$60 subscription cost covers two consecutive volumes beginning with Vol. 171Volume # 24 Category 1 credit hours

Name:

Address:

City: State: Zip:

Daytime Phone: ( )

( ) Check enclosed for $ payable to: American Urological Association Education and Research, Inc.®

Charge to ( ) VISA ( ) MasterCard ( ) AMEX

Card Number: Exp. Date:

Signature:

Please mail or fax registration form to: American Urological Association Education and Research, Inc.®

1000 Corporate Blvd.Linthicum, MD 21090Telephone: 1-410-689-3934Fax: 1-410-689-3937

328

CME QUESTIONS FOR JANUARY 2005 ISSUE OFTHE JOURNAL OF UROLOGY

1. URINARY MATRIX CALCULI: OUR EXPERIENCE AT A SINGLE INSTITUTION (vol. 173, pp. 120–123)

Which of the following treatment modalities is most effectively used in the management of urinary matrix calculi?

a) pelviolithotomyb) chemical dissolutionc) percutaneous ultrasonic lithotripsyd) ureteroscopic stone fragmentatione) extracorporeal shock wave lithotripsy

2. HEALTH RELATED QUALITY OF LIFE BEFORE AND AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY(vol. 173, pp. 175–179)

During the first year after laparoscopic radical prostatectomy there is progressive improvement in health relatedquality of life. By which postoperative time points are the majority of recovery in urinary continence and sexualfunction observed?

Urinary Continence Sexual Functiona) 3 months 3 monthsb) 3 months 6 monthsc) 6 months 6 monthsd) 6 months 12 monthse) 12 months 12 months

3. EVALUATION OF RENAL FUNCTION AND UPPER URINARY TRACT MORPHOLOGY IN THE ILEALORTHOTOPIC NEOBLADDER WITH NO ANTIREFLUX MECHANISM (vol. 173, pp. 144–147)

Regarding continent urinary diversions, in which of the following cases is it more appropriate to construct a directrefluxing ureterointestinal anastomosis?

a) ureterosigmoidostomyb) continent cutaneous pouchc) low pressure orthotopic ileal neobladder with a short afferent limb in mend) sigma rectum pouch (Mainz pouch II)e) low pressure orthotopic ileal neobladder with a short afferent limb in women

4. EXPRESSION OF CYCLOOXYGENASE-2 AND EP4 RECEPTOR IN TRANSITIONAL CELL CARCINOMA OF THEUPPER URINARY TRACT (vol. 173, pp. 56–60)

Which of the following matters associated with carcinogenesis and metastasis is mainly produced by cyclooxygenase-2?

a) p53 oncoproteinb) vascular endothelial growth factorc) thromboxane B2d) prostaglandin E2e) interleukin-6

5. DETECTION OF PROSTATE CANCER WITH 11C-METHIONINE POSITRON EMISSION TOMOGRAPHY (vol. 173,pp. 66–69)

What is the preferred positron emission tomography tracer for the staging of prostate cancer?

a) 18F-fluorodeoxyglucoseb) 11C-methioninec) 11C-acetated) 18F-cholinee) 18F-acetate

The Journal of Urology®

Volume 173, Number 1, January 2005

329